Project Details
Project Description
This project aims were to assess the expression of the SRY gene in post-mortem PD patient brains and to identify potential new drugs to block the SRY gene to halt or slow progression of PD in humans.
Funding awarded to Hudson Institute of Medical Research
Amount awarded - $10,000
Funding awarded to Hudson Institute of Medical Research
Amount awarded - $10,000
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/18 → 31/12/18 |
Keywords
- Parkinson's disease
- neurodegeneration
- disease-modifying therapy
- substantia nigra
- neuroprotection
- brain sex differences